Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)

Delayed Data
As of Dec 02
 +0.63 / +3.79%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc have a median target of 18.00, with a high estimate of 22.00 and a low estimate of 15.50. The median estimate represents a +4.29% increase from the last price of 17.26.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Catalyst Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 15

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 1.00%
Growthannually 96.22%


Growthquarterly -0.69%
Growthannually 52.37%
Key to the earnings and sales forecast charts.